ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $98 | -99.9% | 29,501 | -7.8% | 0.00% | 0.0% |
Q3 2022 | $106,000 | 0.0% | 32,001 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $106,000 | 0.0% | 32,001 | 0.0% | 0.00% | +200.0% |
Q1 2022 | $106,000 | – | 32,001 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2020 | $5,000 | – | 1,500 | +149900.0% | 0.00% | – |
Q3 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 17,349,945 | $25,851,000 | 1.86% |
Defender Capital, LLC. | 2,562,130 | $4,001,000 | 1.39% |
PURA VIDA INVESTMENTS, LLC | 12,223,953 | $18,214,000 | 0.59% |
Penbrook Management LLC | 578,150 | $861,000 | 0.56% |
ACT CAPITAL MANAGEMENT, LLC | 330,000 | $492,000 | 0.52% |
Orbimed Advisors | 3,493,800 | $5,206,000 | 0.08% |
CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $112,000 | 0.07% |
Fort Sheridan Advisors LLC | 135,000 | $201,000 | 0.06% |
AWM Investment Company, Inc. | 241,867 | $360,000 | 0.05% |
WEALTH EFFECTS LLC | 49,000 | $73,000 | 0.03% |